We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
ESROB | Estrella Resources Limited | 0.002 | 0.001 | 100.00% | 12,229,999 | 3 |
APS | Allup Silica Ltd | 0.057 | 0.028 | 96.55% | 27,580,361 | 1,138 |
LPE | Locality Planning Energy Holdings Limited | 0.055 | 0.021 | 61.76% | 33,644,993 | 28 |
HYTO | HyTerra Ltd | 0.003 | 0.001 | 50.00% | 1,500,000 | 3 |
TNC | True North Copper Limited | 0.10 | 0.028 | 38.89% | 7,211,062 | 279 |
RMX | Red Mountain Mining Ltd | 0.002 | 0.0005 | 33.33% | 12,051,679 | 8 |
RIE | Riedel Resources Ltd | 0.004 | 0.001 | 33.33% | 3,981,044 | 14 |
LSR | Lodestar Minerals Limited | 0.002 | 0.0005 | 33.33% | 2,077,222 | 3 |
MXO | Motio Limited | 0.029 | 0.007 | 31.82% | 257,349 | 6 |
MCL | Mighty Craft Limited | 0.025 | 0.006 | 31.58% | 1,325,790 | 26 |
VALDB | Valor Resources Limited | 0.065 | 0.015 | 30.00% | 689,564 | 17 |
Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.
Once-Daily Oral HIF-PH Inhibitor Activates Physiologic Response to Manage Anemia Akebia's Launch Strategy Developed to Drive Toward a Potential New Oral Standard of Care Company to Host Conference Call on Thursday, March 28 at 8:00 AM ET CAMBRIDGE, Mass., March 27, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo® (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at ...
SAN DIEGO, March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the expansion of the inclusion criteria in the open label 15- patient REM-001 study in cutaneous metastatic breast cancer (CMBC) to include patients receiving pembrolizumab (KEYTRUDA®) for at least three months at screening.
PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,639.47 | 1,174.90 | 1.69% | 1.39T | 7,376,737,190 |
ETH | Ethereum | 3,577.40 | 77.34 | 2.21% | 429.65B | 3,937,733,128 |
USDT | Tether USD | 0.9995 | 0.00006 | 0.01% | 97.8B | 1,037,898,827 |
BNB | Binance Coin | 589.68 | 15.55 | 2.71% | 93.17B | 517,323,115 |
SOL | Solana | 187.28 | 1.16 | 0.62% | 82.67B | 1,821,036,200 |
STETH | stETH | 3,530.93 | 66.50 | 1.92% | 34.75B | 13,509,541 |
XRP | Ripple | 0.6237 | 0.0122 | 2.00% | 33.93B | 598,304,485 |
DOGE | Dogecoin | 0.20216 | 0.01212 | 6.38% | 28.58B | 2,190,603,403 |
USDC | USD Coin | 0.99999 | -0.00001 | 0.00% | 28.07B | 1,500,108,899 |
ADA | Cardano | 0.6526 | 0.005 | 0.77% | 22.88B | 201,979,539 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions